¼¼°èÀÇ »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå : Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Oxygen Conservation Devices Market, By Product, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1605758
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 370 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,452,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,370,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,741,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

»ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå ±Ô¸ð´Â 2023³â 17¾ï 6,723¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 11.9%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

»ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå - ½ÃÀå ¿ªÇÐ

È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡

COPD, õ½Ä, Æó¼¶À¯Áõ°ú °°Àº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ »ê¼Ò Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ °í·ÉÈ­ »çȸ¸¦ Áß½ÉÀ¸·Î ÈÞ´ë¿ë ¹× È¿À²ÀûÀÎ »ê¼Ò °ø±Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå µµÀÔÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. Çâ»óµÈ ÆÞ½º Åõ¿© ½Ã½ºÅÛ, °æ·®È­ µî ±â¼ú ¹ßÀüÀ¸·Î ÆíÀǼºÀÌ Çâ»óµÇ¾î ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á Á¢±Ù¼ºÀ» ³ôÀ̱â À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÀçÅÃÄ¡·áÀÇ ±Þ°ÝÇÑ Áõ°¡µµ Å« ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àå±âÀûÀÎ »ê¼Ò ¿ä¹ýÀ» ÇÊ¿ä·Î Çϴ ȯÀÚ Áõ°¡´Â ÀÌ·¯ÇÑ ÀåºñÀÇ Áß¿äÇÑ ¿ªÇÒÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®µéÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 11.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

Á¦Ç° ¼¼ºÐÈ­¿¡ µû¶ó Àú¼öÁöÇü »ê¼Ò °ø±Þ ÀåÄ¡°¡ 2023³â¿¡ °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» º¸¿´½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµ ¼¼ºÐÈ­¸¦ ±âÁØÀ¸·Î 2023³â ȨÄɾ ÁÖ¿ä À¯ÇüÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ÁÖ¿ä ¼öÀÍ¿øÀ¸·Î ºÎ»ó

»ê¼ÒÀúÀåÀåÄ¡ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀåÀº Á¦Ç°, ÃÖÁ¾ ¿ëµµ, Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù. Á¦Ç°º°·Î´Â Àú¼öÁöÇü »ê¼Ò °ø±Þ ÀåÄ¡, Àü±â ±â°è½Ä ¹Úµ¿ ÀåÄ¡, °æ°ü Ä«Å×ÅÍ ¹× ±âŸ Àú¼öÁöÇü »ê¼Ò °ø±Þ ÀåÄ¡°¡ Á¶±â µµÀÔ°ú ȯÀÚ ¹× ÀÇ·á ½Ã¼³ÀÇ ±¤¹üÀ§ÇÑ Ã¤ÅÃÀ¸·Î 2023³â ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. Àú·ù½Ä »ê¼Ò °ø±Þ ÀåÄ¡´Â È¿À²¼º, °æÁ¦¼º, »ç¿ë ÆíÀǼºÀ¸·Î ÀÎÇØ ´ë·®ÀÇ »ê¼Ò¸¦ ÇÊ¿ä·Î Çϴ ȯÀÚ¿¡°Ô ÀûÇÕÇÕ´Ï´Ù. ¶ÇÇÑ, ½É°¢ÇÑ Áõ»óÀ» Ä¡·áÇÒ ¼ö ÀÖ´Â Á¾ÇÕÀûÀÎ ½Ã¼³À» Á¦°øÇÏ´Â º´¿ø ¹× Ŭ¸®´ÐÀÌ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, NHS National Patient Safety Agency¿Í °°Àº Á¤ºÎ ±â°üÀº »ê¼Ò ÀåÄ¡ÀÇ °ü¸® ¹× Á¢±Ù¼ºÀ» °­È­ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ÀÌ´Â º¸Á¸ ±â¼úÀÇ Ã¤Åà Ȯ´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµº°: º´¿ø ¹× Áø·á¼Ò, Àå±â¿ä¾ç½Ã¼³, ÀçÅÿä¾ç. ÀçÅÃÄ¡·á ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀçÅÃÄ¡·á¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁø ¹è°æ¿¡´Â ȯÀÚÀÇ ÆíÀǼº Çâ»ó, º´¿ø ºñ¿ë Àý°¨, °¨¿°¿¡ ´ëÇÑ ¿ì·Á µîÀÌ ÀÖ½À´Ï´Ù. ¿ø°Ý ÀÇ·á¿Í ¿ø°Ý ¸ð´ÏÅ͸µÀÇ ¹ßÀüÀº ƯÈ÷ ¸¸¼º È£Èí±â ÁúȯÀ» ¾Î°í ÀÖ´Â ³ëÀÎÃþ¿¡¼­ Àå±â »ê¼Ò °ø±Þ ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í Áö¿øÀûÀÎ º¸Çè Á¤Ã¥Àº ÀçÅà ġ·á¸¦ ´õ¿í ÃËÁøÇϰí Àü¹ÝÀûÀÎ ÀÇ·á ºñ¿ëÀ» ÁÙÀ̸鼭 »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.

»ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå - Áö¸®Àû ÅëÂû·Â

»ê¼ÒÀúÀåÀåÄ¡(OCD) ½ÃÀåÀº ¸¸¼º È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ °ßÁ¶ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ÀÇ·á ÀÎÇÁ¶ó°¡ Àß °®Ãß¾îÁ® ÀÖ°í COPD¿Í °°Àº ÁúȯÀÇ À¯º´·üÀÌ ³ô¾Æ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. À¯·´Àº ³ëÀÎ Àα¸ Áõ°¡¿Í ÇコÄɾî ÅõÀÚ°¡ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àεµ, Áß±¹ µî ½ÅÈï±¹ÀÇ ÀÎ½Ä Á¦°í¿Í ÀÇ·á ¼­ºñ½º Á¢±Ù¼º Çâ»óÀ¸·Î ÀÎÇØ ½ÃÀåÀÌ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«´Â Àú°³¹ß Áö¿ª¿¡¼­ÀÇ ÇコÄɾî ÅõÀÚ Áõ°¡¿Í ÀÇ·á ±â¼ú Á¢±Ù¼º Çâ»ó¿¡ ÈûÀÔ¾î ¿Ï¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

»ê¼ÒÀúÀåÀåÄ¡ ½ÃÀå - °æÀï ±¸µµ:

»ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀåÀº »ê¼Ò °ø±Þ È¿À²À» ³ôÀ̴ ÷´Ü ±â¼ú¿¡ ÁÖ·ÂÇÏ´Â ÁÖ¿ä ±â¾÷µéÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ßÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â Invacare Corporation, Philips Healthcare, Drive DeVilbiss Healthcare, Inogen, Inc. µîÀÌ ÀÖÀ¸¸ç, ÀÌµé ±â¾÷Àº ´Ù¾çÇÑ ÈÞ´ë¿ë »ê¼Ò ³óÃà±â ¹× »ê¼Ò ÀúÀå ÀåÄ¡¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌµé ±â±â´Â COPD¸¦ Æ÷ÇÔÇÑ ¸¸¼º È£Èí±â Áúȯ °ü¸®¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. °æÀïÀÇ ÇÙ½ÉÀº Á¦Ç°ÀÇ ½Å·Ú¼º, ¹èÅ͸® ¼ö¸í, È޴뼺, »ç¿ë ÆíÀǼºÀÔ´Ï´Ù. ¶ÇÇÑ, °¢ ȸ»ç´Â ÀçÅÃÄ¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ±â±â ¼º´ÉÀ» Çâ»ó½ÃŰ´Â ±â¼ú Çõ½Å¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ê¼Ò ÀúÀå ÀåÄ¡ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå »ê¼Ò ÀúÀå ÀåÄ¡ »ê¾÷ Á¶»ç

Á¦5Àå »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå ±¸µµ

Á¦7Àå »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå - Á¦Ç°º°

Á¦8Àå »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå - ÃÖÁ¾ ¿ëµµº°

Á¦9Àå »ê¼Ò ÀúÀå ÀåÄ¡ ½ÃÀå - Áö¿ªº°

Á¦10Àå ÁÖ¿ä º¥´õ ºÐ¼® - »ê¼Ò ÀúÀå ÀåÄ¡ ¾÷°è

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Oxygen Conservation Devices Market size was valued at USD 1,767.23 million in 2023, expanding at a CAGR of 11.9% from 2024 to 2032.

Oxygen conservation devices are medical technologies designed to optimize oxygen delivery, extending the life of oxygen supplies for patients with respiratory conditions like COPD or pulmonary fibrosis. These devices include conserving cannulas, demand oxygen delivery systems, and reservoir masks, which minimize oxygen waste by delivering it only during inhalation. The efficiency and portability of these devices make them essential for both clinical use and at-home oxygen therapy. With advancements in technology, newer models are compact, energy-efficient, and tailored for improved patient mobility and comfort, catering to the growing demand for long-term oxygen therapy solutions.

Oxygen Conservation Devices Market- Market Dynamics

Increasing prevalence of respiratory diseases

The increasing prevalence of respiratory diseases such as COPD, asthma, and pulmonary fibrosis has escalated the demand for oxygen therapy solutions. Rising awareness about portable and efficient oxygen delivery systems, especially among ageing populations, further boosts market adoption. Technological advancements, including enhanced pulse dose systems and lightweight devices, enhance convenience and fuel demand. Government initiatives promoting healthcare accessibility, coupled with the surge in home healthcare trends, are also significant contributors. Moreover, the rising number of patients requiring long-term oxygen therapy underscores the critical role of these devices.

Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.9% over the forecast period (2024-2032)

Based on Product segmentation, Reservoir oxygen delivery devices were predicted to show maximum market share in the year 2023

Based on End-Use segmentation, homecare was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Oxygen Conservation Devices Market- Segmentation Analysis:

The Global Oxygen Conservation Devices Market is segmented based on Product, End-Use, and region. Based on product: Reservoir Oxygen Delivery Devices, Electromechanical Pulsing Devices, Transtracheal Catheters and Others. Reservoir oxygen delivery devices dominated the market in 2023, driven by their early introduction and widespread adoption among patients and healthcare facilities. Their efficiency, affordability, and ease of use make them ideal for patients requiring high oxygen flow. The growth is further supported by hospitals and clinics offering comprehensive facilities for treating critical conditions. Additionally, government organizations, such as the NHS National Patient Safety Agency, play a significant role in enhancing the management and accessibility of oxygen devices, fostering greater adoption of conservation technologies.

Based on End-Use: Hospitals & Clinics, Long-term Care Units and Home Care. The homecare segment dominates the market. The rising preference for home healthcare is driven by enhanced patient comfort, reduced hospital costs, and infection concerns. Advances in telemedicine and remote monitoring boost demand for long-term oxygen delivery devices, especially among ageing populations with chronic respiratory diseases. Government initiatives and supportive insurance policies further encourage home care, which improves quality of life while lowering overall healthcare expenses.

Oxygen Conservation Devices Market- Geographical Insights

The oxygen conservation devices (OCDs) market is witnessing robust growth due to the rising prevalence of chronic respiratory diseases. North America dominates the market owing to a well-established healthcare infrastructure and a high prevalence of conditions like COPD. In Europe, increasing geriatric populations and healthcare investments drive demand. Asia-Pacific experiences rapid market expansion due to growing awareness and rising healthcare access in emerging economies like India and China. Latin America and the Middle East & Africa show moderate growth, supported by increasing healthcare initiatives and improving access to medical technologies in underdeveloped regions.

Oxygen Conservation Devices Market- Competitive Landscape:

The Oxygen Conservation Devices market is characterized by key players focusing on advanced technology to enhance efficiency in oxygen delivery. Major companies in this field include Invacare Corporation, Philips Healthcare, Drive DeVilbiss Healthcare, and Inogen, Inc., all of which offer a range of portable oxygen concentrators and conservation devices. These devices are widely used in the management of chronic respiratory conditions, including COPD. Competition is centered around product reliability, battery life, portability, and ease of use. Companies are also investing in innovations to improve device performance, aiming to cater to the growing demand for home healthcare solutions.

Recent Developments:

In September 2022, GF Health Products, Inc. made a significant investment in an advanced 3D Fiber Optic Laser Tube Cutting System, enhancing its existing laser cutting capabilities. The integration of the 3D-Tilt Cutting Head ensures faster, more accurate, and consistent production with the assistance of CGI technology. This move reflects GF Health's ongoing commitment to improving its manufacturing processes. Recently, the company has continued to innovate with more sophisticated technologies to maintain its competitive edge in the healthcare products market, particularly in medical devices and related solutions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL OXYGEN CONSERVATION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL OXYGEN CONSERVATION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

GLOBAL OXYGEN CONSERVATION DEVICES MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

GLOBAL OXYGEN CONSERVATION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Oxygen Conservation Devices Market Overview

2. Executive Summary

3. Oxygen Conservation Devices Key Market Trends

4. Oxygen Conservation Devices Industry Study

5. Oxygen Conservation Devices Market: COVID-19 Impact Analysis

6. Oxygen Conservation Devices Market Landscape

7. Oxygen Conservation Devices Market - By Product

8. Oxygen Conservation Devices Market - By End-use

9. Oxygen Conservation Devices Market- By Geography

10. Key Vendor Analysis- Oxygen Conservation Devices Industry

11. 360 Degree Analyst View

12. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â